Exercise training and de-training effects on serum leptin and TNF-α in high fat induced diabetic rats.
De-training
Diabetes
Exercise
High-fat diet
Obesity
Journal
Diabetology & metabolic syndrome
ISSN: 1758-5996
Titre abrégé: Diabetol Metab Syndr
Pays: England
ID NLM: 101488958
Informations de publication
Date de publication:
26 May 2021
26 May 2021
Historique:
received:
12
02
2021
accepted:
18
05
2021
entrez:
27
5
2021
pubmed:
28
5
2021
medline:
28
5
2021
Statut:
epublish
Résumé
Adipocytokines, which are secreted by the adipose tissue, contribute to the pathogenesis of obesity-related complications. To evaluate this assumption, we investigated the effects of aerobic exercise training (AET), resistance exercise training (RET), and 4 weeks of de-training on serum leptin and TNF-α levels in diabetic rats. 36 Wistar rats were divided into normal diet (ND) (control, RET, AET) and high-fat diet (HFD) + STZ (control, RET, AET) groups. Serum insulin, leptin, and TNF-α levels were assessed by commercial ELISA kits. Also fasting blood glucose (FBG), low-density lipoprotein cholesterol (LDL-C), and triglycerides (TG) levels were measured by the colorimetric kits. Diabetes induction increased body weight (BW) and FBG, and decreased insulin compared to the ND rats' groups (p < 0.001). 12-weeks of AET and RET programs in the trained diabetic rats led to a decrease in TG, LDL-C, leptin, TNF-α, and FBG, and an increase in insulin compared to the HFD + STZ-C group (p < 0.001). Besides, there was no difference between AET and RET in improving the variables studied (p > 0.05). Also, de-training led to increased BW, TG, leptin, and TNF-α compared to the end of the exercise training (p < 0.05). The correlation between the variables studied was established at different stages of the study (p < 0.05), and only BW was not correlated with insulin during exercise training and de-training (p > 0.05). These findings indicate that both AET and RET are useful in reducing levels of serum adipocytokines (TNF-α, leptin) in diabetic and non-diabetic rats. At the same time, 4 weeks of de-training was sufficient to lose the metabolic adaptations.
Sections du résumé
BACKGROUND
BACKGROUND
Adipocytokines, which are secreted by the adipose tissue, contribute to the pathogenesis of obesity-related complications. To evaluate this assumption, we investigated the effects of aerobic exercise training (AET), resistance exercise training (RET), and 4 weeks of de-training on serum leptin and TNF-α levels in diabetic rats.
METHOD
METHODS
36 Wistar rats were divided into normal diet (ND) (control, RET, AET) and high-fat diet (HFD) + STZ (control, RET, AET) groups. Serum insulin, leptin, and TNF-α levels were assessed by commercial ELISA kits. Also fasting blood glucose (FBG), low-density lipoprotein cholesterol (LDL-C), and triglycerides (TG) levels were measured by the colorimetric kits.
RESULTS
RESULTS
Diabetes induction increased body weight (BW) and FBG, and decreased insulin compared to the ND rats' groups (p < 0.001). 12-weeks of AET and RET programs in the trained diabetic rats led to a decrease in TG, LDL-C, leptin, TNF-α, and FBG, and an increase in insulin compared to the HFD + STZ-C group (p < 0.001). Besides, there was no difference between AET and RET in improving the variables studied (p > 0.05). Also, de-training led to increased BW, TG, leptin, and TNF-α compared to the end of the exercise training (p < 0.05). The correlation between the variables studied was established at different stages of the study (p < 0.05), and only BW was not correlated with insulin during exercise training and de-training (p > 0.05).
CONCLUSION
CONCLUSIONS
These findings indicate that both AET and RET are useful in reducing levels of serum adipocytokines (TNF-α, leptin) in diabetic and non-diabetic rats. At the same time, 4 weeks of de-training was sufficient to lose the metabolic adaptations.
Identifiants
pubmed: 34039404
doi: 10.1186/s13098-021-00676-x
pii: 10.1186/s13098-021-00676-x
pmc: PMC8157711
doi:
Types de publication
Journal Article
Langues
eng
Pagination
57Références
Diabetes Res Clin Pract. 2011 Dec;94(3):395-403
pubmed: 21890226
Obesity (Silver Spring). 2018 Jan;26(1):14-16
pubmed: 29265774
J Strength Cond Res. 2014 Dec;28(12):3399-410
pubmed: 25028994
J Strength Cond Res. 2002 Aug;16(3):373-82
pubmed: 12173951
Int J Exp Diabetes Res. 2001;2(3):217-23
pubmed: 12369710
Pharmacol Res. 2005 Oct;52(4):313-20
pubmed: 15979893
Eur J Appl Physiol. 2002 Jun;87(2):108-11
pubmed: 12070619
J Mol Endocrinol. 2012 May 29;49(1):R9-17
pubmed: 22448029
Diabetes Care. 2012 Apr;35(4):676-82
pubmed: 22344613
Arch Physiol Biochem. 2019 Oct 7;:1-8
pubmed: 31588806
J Clin Endocrinol Metab. 2005 Nov;90(11):5970-7
pubmed: 16091494
J Neuroendocrinol. 2014 Feb;26(2):58-67
pubmed: 24382295
BMC Musculoskelet Disord. 2019 May 10;20(1):199
pubmed: 31077169
Int J Clin Exp Med. 2014 Aug 15;7(8):2000-8
pubmed: 25232380
J Intern Med. 1999 Jun;245(6):621-5
pubmed: 10395191
J Biol Chem. 2016 Jul 15;291(29):15131-42
pubmed: 27226618
Curr Diabetes Rev. 2012 Mar;8(2):76-83
pubmed: 22229253
Int J Mol Sci. 2019 May 13;20(9):
pubmed: 31085992
Nat Rev Endocrinol. 2012 Apr 03;8(8):457-65
pubmed: 22473333
Int J Obes Relat Metab Disord. 1999 Apr;23(4):355-60
pubmed: 10340812
Nat Rev Mol Cell Biol. 2008 May;9(5):367-77
pubmed: 18401346
J Intern Med. 2013 Aug;274(2):163-75
pubmed: 23432360
PLoS One. 2012;7(12):e52569
pubmed: 23285093
Nutrition. 2009 Mar;25(3):330-9
pubmed: 19062255
Diabet Med. 2010 Sep;27(9):1004-11
pubmed: 20722673
J Appl Physiol (1985). 1997 Jul;83(1):5-10
pubmed: 9216937
J Biomed Sci. 2016 Dec 3;23(1):87
pubmed: 27912756
Diabetes Metab J. 2013 Oct;37(5):358-64
pubmed: 24199165
J Obes Metab Syndr. 2021 Mar 30;30(1):63-71
pubmed: 33653971
Arq Bras Endocrinol Metabol. 2012 Dec;56(9):597-607
pubmed: 23329181
Front Physiol. 2019 May 03;10:527
pubmed: 31130871
Eur J Appl Physiol. 2004 Apr;91(4):382-91
pubmed: 14608461
PLoS One. 2014 Jul 21;9(7):e102373
pubmed: 25047119
Cytokine. 2007 Nov;40(2):75-81
pubmed: 17919919
Int J Endocrinol. 2014;2014:323728
pubmed: 24734042
Acta Diabetol. 2018 Sep;55(9):935-942
pubmed: 29948407
Obes Rev. 2000 Oct;1(2):57-9
pubmed: 12119987
J Chem Neuroanat. 2017 Apr;81:27-33
pubmed: 28179125
Diabetologia. 2021 May;64(5):994-1006
pubmed: 33730188
Eur J Appl Physiol. 2012 May;112(5):1873-80
pubmed: 21922260
Obes Surg. 2003 Aug;13(4):615-21
pubmed: 12935365
J Pak Med Assoc. 2020 Jan;70(1):3-6
pubmed: 31954015
J Neurosci. 2010 Dec 1;30(48):16180-7
pubmed: 21123564
Obesity (Silver Spring). 2010 Nov;18(11):2071-6
pubmed: 20395945
Diabetes Metab Syndr Obes. 2021 Mar 01;14:895-900
pubmed: 33688224
Best Pract Res Clin Endocrinol Metab. 2005 Dec;19(4):649-63
pubmed: 16311223